InVivoMAb anti-mouse TL1A (TNFSF15) BE0323-R050mg from Bio X Cell | Biocompare.com

Supplier Images

InVivoMAb anti-mouse TL1A (TNFSF15)

Be the first to write a review!

Citations:

Supplier Page from
Bio X Cell for
InVivoMAb anti-mouse TL1A (TNFSF15)

The InVivoMAb anti-mouse TL1A (TNFSF15) Antibody from Bio X Cell is a Hamster Monoclonal antibody to TNFSF15. This antibody recognizes Mouse antigen. The InVivoMAb anti-mouse TL1A (TNFSF15) Antibody has been validated for the following applications: In Vivo, Block/Neutralize/Inhibit, and Flow Cytometry.

Description

Bio X Cell InVivoMAb anti-mouse TL1A (TNFSF15) Monoclonal Antibody has the following reported applications: in vivo TL1A neutralization, Flow cytometry. It features greater than 95% purity, ultra-low endotoxin levels, and are preservative, stabilizer, and carrier protein-free

Product Specs
ItemInVivoMAb anti-mouse TL1A (TNFSF15)
CompanyBio X Cell
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberBE0323-R050mg
Quantity50 mg
Applicationsin vivo TL1A neutralization, Flow cytometry
ConcentrationLot specific,typically between 4-11 mg/ml
Conjugate/TagUnconjugated
ReactivityMouse
TargetTL1A
IsotypeIgG
Clone5G4.6
HostArmenian hamster
Antibody TypePrimary Antibody
ImmunogenRecombinant murine TL1A
NCBI Full Gene Nametumor necrosis factor (ligand) superfamily, member 15
NCBI Gene AliasesTl1, Tl1a, Tnlg1b, Vegi
ClonalityMonoclonal
Purity>95%, Determined by SDS-PAGE
FormatPBS, pH 7.0, Contains no stabilizers or preservatives
Research AreaCytokine and Chemokine, Cytokine Receptor, Immunology, Innate Immunity

Specifications/Features

Other available quantities: Available in 1, 5, 10, 25, 50, 100 mg and bulk sizes. Academic discount available.

Endotoxin: <2EU/mg (<0.002EU/µg), Determined by LAL gel clotting assay

Add to Compare List

Bio X Cell

Bio X Cell

39 Labombard Rd

Lebanon, NH 03766

United States

Phone: 1-866-787-3444

Email: customerservice@bxcell.com

Company Profile

Website: bioxcell.com

(1) The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cellsJournal of immunology (Baltimore, Md. : 1950)April 15, 2015Richard AC, Tan C, Hawley ET, Gomez-Rodriguez J, Goswami R, Yang XP, Cruz AC, Penumetcha P, Hayes ET, Pelletier M, et al.

(2) The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammationMucosal immunologyMarch 1, 2011Meylan F, Song YJ, Fuss I, Villarreal S, Kahle E, Malm IJ, Acharya K, Ramos HL, Lo L, Mentink-Kane MM, et al.

Be the First to Write a Review!